What does “glucagon receptor agonism” mean in retatrutide?
retatrutideglucagonmechanism
Glucagon receptor agonism refers to activity at the glucagon receptor, a pathway involved in energy regulation and metabolic signaling.
In research contexts, adding glucagon receptor activity (alongside GLP-1 and GIP) is studied as a way to influence multiple metabolic pathways at once.
For research use only. Not medical advice.
Related questions
- What is retatrutide and how is it different from tirzepatide?
- What is the difference between GLP-1, GIP, and glucagon receptors?
- What are GLP-1 receptor agonists?
- Semaglutide vs tirzepatide vs retatrutide: what’s the difference (research overview)?
- Is semaglutide a GLP-1?
- What is tirzepatide (GIP/GLP-1) and how is it different from semaglutide?
Browse all FAQs about research peptides, sourcing, and Peptide Library.
View all FAQs